Byron Myers's Linkedin Analytics

A results-oriented, decisive and innovative entrepreneur and business leader, Byron Myers started, developed and scaled a business that addressed a market opportunity and created a solution based on patients’ needs. The business was subsequently recognized as having shaped the future of the oxygen therapy industry. He pioneered a disruptive, innovative direct-to-consumer sales/marketing business model, managed growth and profitability in pre and post IPO phases, and served as one of the company’s executive officers. Byron led all sales and marketing strategy, personnel, operations and results globally and across consumer, B2B, and physician business channels. His expertise in domestic and international market and technology assessment, product management and business development, strategic market positioning, and multi-channel product sales informs all his work, as do his collaborative spirit, and his ability to build, develop and lead diverse and high-performing teams. Byron developed a respiratory technology startup and was key to its growth enabling an IPO in 2014, (NASDAQ: INGN). The Company is now valued >$1.5B and has been recognized as having shaped the future of the oxygen therapy industry by Wall Street analyst reports, industry market research intelligence, competitive technology development, and new Medicare reimbursement. Inogen disrupted the oxygen-care marketplace and the go-to-market (GTM) strategy, targeting patients directly, and expanded market opportunities with a better solution for both patients and providers: patients benefited from an enhanced quality-of-life (greater independence), and business partners (home health-care providers) benefited from enhanced profitability.